Vita Coco二季度业绩超预期并上调全年指引，但一次性关税退款与下半年成本压力削弱追多价值

Earnings Call Insights: The Vita Coco Company (COCO) Q2 2026
Management View
- “I’m pleased to announce the acquisition of Copra Inc.” (Co-Founder, Executive Chairman & President Michael Kirban) and “we estimate that this super premium cold segment represents approximately 13% of U.S. coconut water sales,” with Copra positioned as “the leading supplier of private label products for this segment.”
- “Our net sales in the quarter were up 28%, driven by the strong growth of Vita Coco Coconut Water of 21% and growth in private label of 83%.” (CEO & Director Martin Roper) He also said, “we lost several weeks of production…representing approximately 1% of our full network annual production” due to the General Santos, Philippines earthquake.
- “For the second quarter, net sales increased $47 million or 28% year-over-year to $216 million.” (CFO & Interim Chief Accounting Officer Corey Baker) He added, “gross margins finished at 49% for the quarter,” and “tariff refunds improved gross margin within the quarter by approximately 700 basis points.”
Outlook
- “We now expect net sales between $790 million and $805 million.” (CFO Baker)
- “We expect gross margin for the full year of approximately 40%, delivering adjusted EBITDA of $154 million to $161 million.” (CFO Baker)
- “We now expect full year private label net sales growth of 90% to 100% in the U.S.” (CFO Baker) and “consolidated growth of Vita Coco Coconut Water net sales of high teens to 20%.”
- Versus Q1, management raised full-year guidance and added Copra; in Q1, the company said tariff refunds were not assumed, while in Q2 the company incorporated them into guidance.
Financial Results
- “Net income attributable to shareholders for the quarter was $49 million or $0.82 per diluted share.” (CFO Baker)
- “Q2 2026 adjusted EBITDA was $67 million or 31% of net sales.” (CFO Baker)
- “As of June 30, 2026…total cash on hand of $279 million and no debt under our revolving credit facility.” (CFO Baker) He also said, “in July, our Board approved a $40 million increase in our stock buyback authorization…$61 million remaining under the total $105 million authorized.”
- On Copra deal terms, “the first payment of $175 million…consisting of approximately 80% cash and 20% stock,” plus “additional consideration…in 2029…a floor of $45 million and a cap of $100 million.” (CFO Baker) He added, “Copra projects their full year calendar net sales for 2026 to be above $100 million.”
Q&A
- Bonnie Herzog, Goldman Sachs Group, Inc., Research Division: Asked why guidance implies 2H deceleration and margin deleverage; CFO Baker: “we do run into the inventory builds at distributor, Walmart load-in,” and “inflation is starting to hit Q3, Q4,” while Copra integration drove “a bit of conservativeness on the SG&A.”
- Peter Galbo, BofA Securities, Research Division: Asked whether Copra capacity can support Vita Coco; Executive Chairman Kirban: “it’s a different actual liquid than what is in Vita Coco,” so “the 2 capacity builds…they’re separate.” Galbo also asked about shipments vs. scans; CFO Baker: “it’s just a shipment timing item, primarily with the MBM.”
- Christopher Carey, Wells Fargo Securities, LLC, Research Division: Asked about back-half category assumptions; CFO Baker: “we’re basing the guidance on the 20s, low 20s.” On Copra brand vs private label and margins, Executive Chairman Kirban said the goal is “eventually be the largest player in that segment…through mostly brand,” while CFO Baker said, “it’s operating with a large percentage of private label…lower gross margin.” Carey asked Copra profitability; Executive Chairman Kirban: “No, it’s a profitable business, and it’s included.”
- Jon Andersen, William Blair & Company L.L.C., Research Division: Asked private label strength and run-rate; CEO Roper cited “regain regions and the new tetra customer,” and Europe where “Germany…is exploding.” CFO Baker added launch benefits from “a distribution pipeline fill.” Andersen asked EBITDA bridge; CFO Baker: “the tariffs were not in previously, they’re now in.”
- Eric Serotta, Morgan Stanley, Research Division: Asked why buy Copra now; Executive Chairman Kirban cited super premium growth and said the deal brings “a…manufacturing opportunity and a supply chain opportunity.” Serotta asked about freight; CEO Roper: “we still view that there is excess capacity versus demand,” and increases would flow “in Q3 and…Q4.”
- Eric Des Lauriers, Craig-Hallum Capital Group LLC, Research Division: Asked super premium private label dynamics; Executive Chairman Kirban: “they’re providing both” shelf-stable and refrigerated offerings. CEO Roper said Nam Hom private label sells “at 2x what Vita Coco does on a per liter basis,” and pricing will likely be “sort of on a cost-plus basis.” On vertical integration, CEO Roper said the current model remains “asset-light…for at least the next couple of years.”
- James Salera, Stephens Inc., Research Division: Asked if guidance is capped by capacity; CEO Roper: “we are currently running closer to 95% capacity,” and capacity loss from the earthquake was “about 1%.” On 2027 flex, CEO Roper: “there always is, and we’re talking.”
- Kaumil Gajrawala, Jefferies: Asked whether Nam Hom sourcing can scale; Executive Chairman Kirban: “there is capacity to be had today, significant capacity.” He also said the product “ships chilled and stays chilled all the way through the supply chain.”
- Robert Ottenstein, Evercore ISI Institutional Equities, Research Division: Asked super premium demographics and why private label is prominent; CEO Roper said consumers are “pretty similar…maybe a little higher income and a little older,” and private label strength is “partially related to Costco.” On Costco private label supplier, CEO Roper: “we would never comment publicly on who provides private label.”
Sentiment Analysis
- Analysts were slightly negative to pressing on 2H deceleration, margins, and integration risk, including “your guidance…implies a deceleration” (Bonnie Herzog, Goldman Sachs Group, Inc., Research Division) and repeated probing on Copra economics.
- Management tone was positive and confident in demand and strategy, including “our confidence in the category and Vita Coco brand trends remains very high.” (CEO Roper) Management also acknowledged uncertainty on inflation: “it is unclear how long these [freight] surcharges will remain effective.” (CEO Roper)
- Versus Q1, management’s confidence remained high, but Q2 added more operational risk detail (earthquake disruption) and more explicit discussion of cost inflation timing into Q3/Q4.
Quarter-over-quarter comparison
- The largest strategic change was the Q2 Copra acquisition; Q1 emphasized an “asset-light model,” while Q2 added ownership of a Thailand facility and committed Copra CapEx (“approximately $11 million”).
- Guidance shifted materially upward (net sales and adjusted EBITDA ranges increased) and incorporated tariff refunds that Q1 explicitly excluded from guidance.
- Q1 freight coverage was described as “approximately 25%,” while Q2 said new contracts “provide us with approximately 50% coverage” for the balance of the year.
- Analyst questioning shifted from Q1 phasing and promotions to Q2 integration execution, super premium segment sizing, cold-chain logistics, and capacity ceilings.
Risks and Concerns
- Cost inflation and margin pressure: “Most of these increases will start impacting our gross margin mid-third quarter.” (CEO Roper)
- Supply disruption: “We lost several weeks of production…representing approximately 1% of our full network annual production.” (CEO Roper)
- Capacity tightness: “We are currently running closer to 95% capacity.” (CEO Roper)
- Integration uncertainty: “It just kind of closed yesterday…we are cautious in trying to understand the integration costs.” (CFO Baker)
Final Takeaway
Management described accelerating coconut water demand and share gains across major markets, raised full-year 2026 guidance to $790 million-$805 million in net sales and $154 million-$161 million in adjusted EBITDA, and framed the Copra acquisition as a manufacturing-led entry into the refrigerated super premium Nam Hom segment, while flagging second-half gross-margin pressure from packaging, logistics, and ocean-freight inflation alongside near-term capacity constraints and integration execution risks.
Read the full Earnings Call Transcript